Molbio Diagnostics Ltd vs Tarsons Products Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2023 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Tarsons Products Ltd changed from 37.2 on March 2022 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Tarsons Products Ltd changed from ₹ 3746 crore on March 2022 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The revenue of Tarsons Products Ltd for the Jun '26 is ₹ 116.22 crore as compare to the Mar '26 revenue of ₹ 127.76 crore. This represent the decline of -9.03% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The ebitda of Tarsons Products Ltd for the Jun '26 is ₹ 31.96 crore as compare to the Mar '26 ebitda of ₹ 41.1 crore. This represent the decline of -22.24% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The net profit of Tarsons Products Ltd changed from ₹ 4.02 crore to ₹ -1.44 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Tarsons Products Ltd changed from 20.76 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Tarsons Products Ltd

Tarsons Products Limited was incorporated as Tarsons Products Private Limited on July 5, 1983.
The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Tarsons Products Limited on June 14, 2021. Tarsons is an Indian labware Company engaged in designing, developing, manufacturing and marketing of consumables', reusables' and others' (including benchtop equipment), used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies and hospitals.
The Company is also engaged in the manufacturing of wide range of quality labware products which helps scientific discovery and improve healthcare.
Tarsons currently operate through five manufacturing facilities located in West Bengal.

FAQs for the comparison of null and Tarsons Products Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Tarsons Products Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Tarsons Products Ltd is 1,595 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Tarsons Products Ltd?

The stock performance of Molbio Diagnostics Ltd and Tarsons Products Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Tarsons Products Ltd?

As of October 25, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Tarsons Products Ltd stock price is INR ₹299.95.

How do dividend payouts of Molbio Diagnostics Ltd and Tarsons Products Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Tarsons Products Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.